Ticker Details
Nautilus Biotechnology, Inc.
IPO Date:	August 7, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$384.76M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 3.51%
Avg Daily Range (30 D):	$0.17 | 5.73%
Avg Daily Range (90 D):	$0.12 | 4.70%

Institutional Daily Volume
Avg Daily Volume:	.19M
Avg Daily Volume (30 D):	.3M
Avg Daily Volume (90 D):	.23M

Trade Size
Avg Trade Size (Sh.):	131
Avg Trade Size (Sh.) (30 D):	111
Avg Trade Size (Sh.) (90 D):	111

Institutional Trades
Total Institutional Trades:	35
Avg Institutional Trade:	$1.5M
Avg Institutional Trade (30 D):	$2.57M
Avg Institutional Trade (90 D):	$2.57M
Avg Institutional Trade Volume:	.44M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.99M
Avg Closing Trade (30 D):	$2.57M
Avg Closing Trade (90 D):	$2.57M
Avg Closing Volume:	654.98K

News

May 3, 2024 @ 4:00 PM Nautilus Biotechnology (NAUT) Upgraded to Buy: Her... Source: Zacks Equity Research

Apr 30, 2024 @ 12:00 PM Nautilus Biotechnology Reports First Quarter 2024 ... Source: Nautilus Biotechnology Inc.

Feb 22, 2024 @ 1:00 PM Nautilus Biotechnology to Participate in the TD Co... Source: Nautilus Biotechnology Inc.

Nov 1, 2023 @ 12:05 PM Nautilus Biotechnology Appoints Martin Huber, Ph.D... Source: Nautilus Biotechnology Inc.

Oct 31, 2023 @ 12:05 PM Nautilus Biotechnology Reports Third Quarter 2023 ... Source: Nautilus Biotechnology Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.47	$-.11	$-.47
Diluted EPS	$-.47	$-.11	$-.47
Revenue
Gross Profit
Net Income / Loss	$-59M	$-13.78M	$-59M
Operating Income / Loss
Cost of Revenue
Net Cash Flow	$-15.26M	$-11.49M	$-15.26M
PE Ratio